The estimated Net Worth of Davide Molho is at least 13.6 百万$ dollars as of 24 July 2018. Davide Molho owns over 18,773 units of Charles River Laboratories International stock worth over 3,321,036$ and over the last 14 years Davide sold CRL stock worth over 10,232,085$.
Davide has made over 23 trades of the Charles River Laboratories International stock since 2013, according to the Form 4 filled with the SEC. Most recently Davide sold 18,773 units of CRL stock worth 2,346,625$ on 24 July 2018.
The largest trade Davide's ever made was exercising 30,667 units of Charles River Laboratories International stock on 6 April 2016 worth over 1,164,119$. On average, Davide trades about 5,411 units every 37 days since 2011. As of 24 July 2018 Davide still owns at least 17,155 units of Charles River Laboratories International stock.
You can see the complete history of Davide Molho stock trades at the bottom of the page.
Over the last 22 years, insiders at Charles River Laboratories International have traded over 220,588,205$ worth of Charles River Laboratories International stock and bought 18,392 units worth 3,841,397$ . The most active insiders traders include James C Foster、Richard F Wallman、David P Johst. On average, Charles River Laboratories International executives and independent directors trade stock every 14 days with the average trade being worth of 2,223,188$. The most recent stock trade was executed by Joseph W La Plume on 8 August 2024, trading 1,780 units of CRL stock currently worth 354,861$.
charles river provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. #drugdiscovery #biotech #biotechnology #pharmaceuticals #cro
Charles River Laboratories International executives and other stock owners filed with the SEC include: